New development of the Chinese bioanalytical landscape and update of the China Bioanalysis Forum (CBF)

Bioanalysis. 2019 Apr;11(7):567-569. doi: 10.4155/bio-2019-0010. Epub 2019 Apr 4.

¹ Bioanalytical Chemistry, Covance Pharmaceutical R&D (Shanghai) Co., Ltd, Building #3, No.3377 Kangxin.SIMZ, Pudong, Shanghai 201318, PR China.
² Phanes Biopharmaceuticals, Songshan Lake Science and Technology Industry Park, Dongguan, Guangdong 523808, PR China.
³ United-Power Pharma Tech Co., Ltd (UPP), 2F, Tower B, No. 33Science Park Road, Changping District, Beijing 102206, PR China.
⁴ Center for DMPK Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 501 Haike Rd, Zhangjiang Hi Tech Park, Shanghai 201203, PR China.

No abstract available

Keywords: China Bioanalysis Forum (CBF); China regulatory reform; drug innovation; regulated bioanalysis.

MeSH terms